NYSE : ABT
Abbott Laboratories — Financial statements
Healthcare · Medical Devices · United States
Last price 106.2 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 183.77B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Abbott Laboratories (ABT) reported revenue of 48.23B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 48.23B | 44.33B | 41.95B | 40.11B | 43.65B | 43.08B |
| Cost of Revenue | 20.70B | 19.21B | 18.64B | 17.92B | 19.08B | 18.08B |
| Gross Profit | 27.53B | 25.12B | 23.31B | 22.19B | 24.57B | 25.00B |
| Selling, General & Admin | 13.94B | 11.63B | 11.11B | 10.38B | 10.70B | 11.01B |
| Research & Development | 3.27B | 2.89B | 2.82B | 2.62B | 2.74B | 2.74B |
| Amortization of Goodwill & Intangibles | 2.34B | 1.68B | 1.88B | 1.97B | 2.01B | 2.05B |
| Operating Expenses | 19.55B | 16.20B | 15.81B | 14.97B | 15.46B | 15.79B |
| Operating Income | 7.98B | 8.92B | 7.50B | 7.22B | 9.11B | 9.20B |
| Interest Expense | -1.01B | -493.00M | -559.00M | -637.00M | -558.00M | -533.00M |
| Interest & Investment Income | 308.00M | 308.00M | 344.00M | 385.00M | 183.00M | 43.00M |
| Currency Exchange Gain (Loss) | 30.00M | 50.00M | 27.00M | -41.00M | -2.00M | -1.00M |
| Other Non Operating Income (Expenses) | -4.00M | -42.00M | -23.00M | -19.00M | -85.00M | 7.00M |
| EBT Excluding Unusual Items | 7.30B | 8.74B | 7.29B | 6.91B | 8.65B | 8.72B |
| Merger & Restructuring Charges | -740.00M | -274.00M | -129.00M | -144.00M | -234.00M | -509.00M |
| Gain (Loss) on Sale of Assets | -143.00M | |||||
| Asset Writedown | -100.00M | -111.00M | ||||
| Pretax Income | 6.56B | 8.47B | 7.01B | 6.66B | 8.31B | 8.21B |
| Income Tax Expense | 1.86B | 1.94B | -6.39B | 941.00M | 1.37B | 1.14B |
| Earnings From Continuing Operations | 4.70B | 6.52B | 13.40B | 5.72B | 6.93B | 7.07B |
| Net Income | 4.70B | 6.52B | 13.40B | 5.72B | 6.93B | 7.07B |
| Preferred Dividends & Other Adjustments | 24.00M | 24.00M | 2.00M | 23.00M | 28.00M | 29.00M |
| Net Income to Common | 4.68B | 6.50B | 13.40B | 5.70B | 6.91B | 7.04B |
| Shares Outstanding (Basic) | 1.74B | 1.74B | 1.74B | 1.74B | 1.75B | 1.77B |
| Shares Outstanding (Diluted) | 1.74B | 1.75B | 1.75B | 1.75B | 1.76B | 1.79B |
| EPS (Basic) | 2.69 | 3.73 | 7.70 | 3.28 | 3.94 | 3.97 |
| EPS (Diluted) | 2.69 | 3.72 | 7.64 | 3.26 | 3.91 | 3.94 |
| Free Cash Flow | 7.39B | 6.35B | 5.06B | 7.80B | 8.65B | |
| Free Cash Flow Per Share | 4.23 | 3.63 | 2.89 | 4.42 | 4.83 | |
| Dividend Per Share | 2.52 | 2.40 | 2.24 | 2.08 | 1.92 | 1.82 |
| Gross Margin | 57.08% | 56.66% | 55.56% | 55.32% | 56.28% | 58.03% |
| Operating Margin | 16.55% | 20.12% | 17.87% | 18.00% | 20.88% | 21.37% |
| Profit Margin | 9.70% | 14.66% | 31.94% | 14.21% | 15.82% | 16.35% |
| Free Cash Flow Margin | 16.68% | 15.14% | 12.61% | 17.88% | 20.08% | |
| EBITDA | 11.95B | 12.03B | 10.71B | 10.46B | 12.38B | 12.74B |
| EBITDA Margin | 24.79% | 27.15% | 25.54% | 26.09% | 28.36% | 29.58% |
| D&A For EBITDA | 3.97B | 3.12B | 3.22B | 3.24B | 3.27B | 3.54B |
| EBIT | 7.98B | 8.92B | 7.50B | 7.22B | 9.11B | 9.20B |
| EBIT Margin | 16.55% | 20.12% | 17.87% | 18.00% | 20.88% | 21.37% |
| Effective Tax Rate | 28.36% | 22.94% | 14.12% | 16.53% | 13.88% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 8.52B | 7.62B | 6.90B | 9.88B | 9.80B | |
| Short-Term Investments | 417.00M | 351.00M | 383.00M | 288.00M | 450.00M | |
| Trading Asset Securities | 1.00M | |||||
| Cash & Short-Term Investments | 5.60B | 8.94B | 7.97B | 7.28B | 10.17B | 10.25B |
| Receivables | 7.93B | 6.92B | 6.57B | 6.22B | 6.49B | |
| Inventory | 6.49B | 6.19B | 6.57B | 6.17B | 5.16B | |
| Prepaid Expenses | 2.53B | 2.18B | 2.09B | 2.25B | 2.05B | |
| Other Current Assets | 108.00M | 390.00M | 169.00M | 412.00M | 292.00M | |
| Total Current Assets | 26.00B | 23.66B | 22.67B | 25.22B | 24.24B | |
| Property, Plant & Equipment | 12.94B | 11.73B | 11.28B | 10.28B | 10.11B | |
| Long-Term Investments | 595.00M | 573.00M | 485.00M | 468.00M | 512.00M | |
| Goodwill | 24.04B | 23.11B | 23.68B | 22.80B | 23.23B | |
| Other Intangible Assets | 5.53B | 6.65B | 8.81B | 10.45B | 12.74B | |
| Long-Term Deferred Tax Assets | 5.97B | |||||
| Other Long-Term Assets | 17.62B | 15.70B | 314.00M | 5.21B | 4.36B | |
| Total Assets | 86.71B | 81.41B | 73.21B | 74.44B | 75.20B | |
| Accounts Payable | 4.24B | 4.20B | 4.29B | 4.61B | 4.41B | |
| Accrued Expenses | 7.17B | 6.20B | 6.54B | 6.92B | 6.46B | |
| Current Portion of Long-Term Debt | 3.03B | 1.50B | 1.08B | 2.27B | 754.00M | |
| Current Portion of Leases | 276.00M | 254.00M | 245.00M | 230.00M | 245.00M | |
| Current Income Taxes Payable | 569.00M | 594.00M | 492.00M | 343.00M | 306.00M | |
| Other Current Liabilities | 1.21B | 1.41B | 1.19B | 1.11B | 928.00M | |
| Total Current Liabilities | 16.50B | 14.16B | 13.84B | 15.49B | 13.11B | |
| Long-Term Debt | 9.90B | 12.68B | 13.69B | 14.52B | 17.30B | |
| Long-Term Leases | 931.00M | 896.00M | 949.00M | 943.00M | 956.00M | |
| Pension & Post-Retirement Benefits | 2.12B | 1.88B | 1.96B | 1.78B | 2.74B | |
| Long-Term Deferred Tax Liabilities | 559.00M | 512.00M | 568.00M | 991.00M | 1.39B | |
| Other Long-Term Liabilities | 3.94B | 3.39B | 3.37B | 3.80B | 3.69B | |
| Total Liabilities | 33.94B | 33.51B | 34.39B | 37.53B | 39.17B | |
| Common Stock | 25.53B | 25.15B | 24.87B | 24.71B | 24.47B | |
| Retained Earnings | 49.78B | 47.26B | 37.55B | 35.26B | 31.53B | |
| Treasury Stock | -17.18B | -16.84B | -15.98B | -15.23B | -11.82B | |
| Comprehensive Income & Other | -6.00B | -7.91B | -7.84B | -8.05B | -8.37B | |
| Total Common Equity | 51.11B | 52.13B | 47.66B | 38.60B | 36.69B | 35.80B |
| Minority Interest | 641.00M | 237.00M | 224.00M | 219.00M | 222.00M | |
| Shareholders' Equity | 51.76B | 52.77B | 47.90B | 38.83B | 36.91B | 36.02B |
| Total Liabilities & Equity | 86.71B | 81.41B | 73.21B | 74.44B | 75.20B | |
| Total Debt | 32.72B | 14.14B | 15.33B | 15.97B | 17.97B | 19.25B |
| Net Cash (Debt) | -27.12B | -5.20B | -7.36B | -8.69B | -7.80B | -9.00B |
| Net Cash Per Share | -15.55 | -2.97 | -4.21 | -4.97 | -4.42 | -5.03 |
| Filing Date Shares Outstanding | 1.74B | 1.74B | 1.73B | 1.74B | 1.74B | 1.76B |
| Total Common Shares Outstanding | 1.74B | 1.74B | 1.73B | 1.73B | 1.74B | 1.76B |
| Working Capital | 9.50B | 9.50B | 8.83B | 9.73B | 11.13B | |
| Book Value Per Share | 29.54 | 30.02 | 27.52 | 22.26 | 21.11 | 20.29 |
| Tangible Book Value | -1.34B | 22.57B | 17.91B | 6.11B | 3.43B | -168.00M |
| Tangible Book Value Per Share | -0.78 | 13.00 | 10.34 | 3.52 | 1.98 | -0.10 |
| Land | 541.00M | 528.00M | 529.00M | 511.00M | 525.00M | |
| Buildings | 4.54B | 4.21B | 4.16B | 4.05B | 4.01B | |
| Machinery | 17.57B | 15.52B | 15.18B | 14.16B | 13.53B | |
| Construction In Progress | 2.57B | 2.49B | 2.06B | 1.48B | 1.30B |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 6.52B | 13.40B | 5.72B | 6.93B | 7.07B | |
| Depreciation & Amortization | 3.12B | 3.22B | 3.24B | 3.27B | 3.54B | |
| Loss (Gain) From Sale of Assets | 65.00M | 482.00M | 126.00M | 215.00M | 55.00M | |
| Stock-Based Compensation | 664.00M | 673.00M | 644.00M | 685.00M | 640.00M | |
| Change in Accounts Receivable | -652.00M | -691.00M | -356.00M | -68.00M | -383.00M | |
| Change in Inventory | 195.00M | -58.00M | -232.00M | -1.41B | -456.00M | |
| Change in Accounts Payable | 954.00M | 356.00M | -760.00M | 420.00M | 1.29B | |
| Change in Income Taxes | -5.00M | -8.03B | -585.00M | -383.00M | -908.00M | |
| Change in Other Net Operating Assets | -1.29B | -796.00M | -542.00M | -75.00M | -312.00M | |
| Operating Cash Flow | 9.57B | 8.56B | 7.26B | 9.58B | 10.53B | |
| Capital Expenditures | -2.17B | -2.21B | -2.20B | -1.78B | -1.89B | |
| Cash Acquisitions | -105.00M | -877.00M | -187.00M | |||
| Divestitures | 1.00M | 40.00M | 48.00M | 134.00M | ||
| Investment in Securities | -164.00M | -141.00M | -116.00M | -33.00M | -96.00M | |
| Other Investing Activities | 18.00M | 9.00M | 22.00M | 22.00M | 26.00M | |
| Investing Cash Flow | -2.42B | -2.34B | -3.13B | -1.74B | -2.01B | |
| Short-Term Debt Issued | 21.00M | 47.00M | ||||
| Long-Term Debt Issued | 5.00M | 223.00M | 2.00M | 7.00M | 4.00M | |
| Total Debt Issued | 5.00M | 223.00M | 23.00M | 54.00M | 4.00M | |
| Short-Term Debt Repaid | -115.00M | -100.00M | -204.00M | |||
| Long-Term Debt Repaid | -1.50B | -660.00M | -2.50B | -753.00M | -48.00M | |
| Total Debt Repaid | -1.62B | -760.00M | -2.50B | -753.00M | -252.00M | |
| Net Debt Issued (Repaid) | -1.61B | -537.00M | -2.48B | -699.00M | -248.00M | |
| Issuance of Common Stock | 396.00M | 264.00M | 167.00M | 167.00M | 255.00M | |
| Repurchase of Common Stock | -893.00M | -1.29B | -1.23B | -3.79B | -2.30B | |
| Common Dividends Paid | -4.12B | -3.84B | -3.56B | -3.31B | -3.20B | |
| Other Financing Activities | -82.00M | |||||
| Financing Cash Flow | -6.31B | -5.40B | -7.09B | -7.64B | -5.49B | |
| Foreign Exchange Rate Adjustments | 71.00M | -96.00M | -23.00M | -122.00M | -70.00M | |
| Net Cash Flow | 906.00M | 720.00M | -2.99B | 83.00M | 2.96B | |
| Free Cash Flow | 7.39B | 6.35B | 5.06B | 7.80B | 8.65B | |
| Free Cash Flow Margin | 16.68% | 15.14% | 12.61% | 17.88% | 20.08% | |
| Free Cash Flow Per Share | 4.23 | 3.63 | 2.89 | 4.42 | 4.83 | |
| Levered Free Cash Flow | 6.29B | 5.61B | 4.99B | 7.34B | 7.68B | |
| Unlevered Free Cash Flow | 6.60B | 5.96B | 5.39B | 7.69B | 8.01B | |
| Cash Interest Paid | 545.00M | 604.00M | 662.00M | 563.00M | 544.00M | |
| Cash Income Tax Paid | 1.93B | 1.72B | 1.48B | 1.86B | 1.94B | |
| Change in Working Capital | -803.00M | -9.22B | -2.48B | -1.52B | -771.00M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 187.59B | 217.86B | 196.18B | 191.09B | 191.43B | 241.36B |
| Enterprise Value | 214.71B | 223.41B | 203.67B | 199.95B | 198.31B | 250.29B |
| Last Close Price | 106.20 | 122.25 | 108.31 | 103.34 | 101.06 | 127.41 |
| PE Ratio | 40.29 | 33.52 | 14.64 | 33.52 | 27.72 | 34.27 |
| Forward PE | 18.58 | 22.63 | 22.39 | 24.22 | 26.64 | 30.05 |
| PS Ratio | 3.81 | 4.92 | 4.68 | 4.76 | 4.38 | 5.60 |
| PB Ratio | 3.60 | 4.13 | 4.10 | 4.92 | 5.19 | 6.70 |
| P/TBV Ratio | 9.65 | 10.96 | 31.28 | 55.76 | ||
| P/FCF Ratio | 23.49 | 29.46 | 30.89 | 37.77 | 24.53 | 27.91 |
| P/OCF Ratio | 18.55 | 22.77 | 22.92 | 26.32 | 19.98 | 22.91 |
| PEG Ratio | 1.94 | 2.35 | 2.61 | 2.85 | 5.16 | 2.38 |
| EV/Sales Ratio | 4.37 | 5.04 | 4.86 | 4.99 | 4.54 | 5.81 |
| EV/EBITDA Ratio | 17.64 | 18.57 | 19.01 | 19.11 | 16.02 | 19.64 |
| EV/EBIT Ratio | 26.42 | 25.05 | 27.17 | 27.69 | 21.76 | 27.19 |
| EV/FCF Ratio | 26.95 | 30.21 | 32.07 | 39.52 | 25.41 | 28.94 |
| Debt / Equity Ratio | 0.63 | 0.27 | 0.32 | 0.41 | 0.49 | 0.53 |
| Debt / EBITDA Ratio | 2.65 | 1.14 | 1.38 | 1.48 | 1.41 | 1.47 |
| Debt / FCF Ratio | 1.91 | 2.41 | 3.16 | 2.30 | 2.23 | |
| Net Debt / Equity Ratio | 0.52 | 0.10 | 0.15 | 0.22 | 0.21 | 0.25 |
| Net Debt / EBITDA Ratio | 2.27 | 0.43 | 0.69 | 0.83 | 0.63 | 0.71 |
| Net Debt / FCF Ratio | 0.70 | 1.16 | 1.72 | 1.00 | 1.04 | |
| Asset Turnover | 0.53 | 0.54 | 0.54 | 0.58 | 0.58 | |
| Inventory Turnover | 3.03 | 2.92 | 2.81 | 3.37 | 3.56 | |
| Quick Ratio | 1.02 | 1.05 | 1.00 | 1.06 | 1.28 | |
| Current Ratio | 1.58 | 1.67 | 1.64 | 1.63 | 1.85 | |
| Return on Equity (ROE) | 12.96% | 30.91% | 15.11% | 19.01% | 20.49% | |
| Return on Assets (ROA) | 6.63% | 6.06% | 6.11% | 7.61% | 7.79% | |
| Return on Invested Capital (ROIC) | 7.25% | 12.14% | 14.59% | 13.45% | 16.96% | 17.46% |
| Return on Capital Employed (ROCE) | 12.70% | 11.10% | 12.20% | 15.50% | 14.80% | |
| Earnings Yield | 2.48% | 3.00% | 6.83% | 3.00% | 3.62% | 2.93% |
| FCF Yield | 4.26% | 3.39% | 3.24% | 2.65% | 4.08% | 3.58% |
| Dividend Yield | 2.33% | 1.91% | 1.98% | 1.89% | 1.74% | 1.33% |
| Payout Ratio | 93.66% | 63.09% | 28.62% | 62.13% | 47.73% | 45.28% |
| Buyback Yield / Dilution | 0.24% | -0.06% | 0.06% | 0.85% | 1.40% | -0.17% |
| Total Shareholder Return | 2.62% | 1.86% | 2.03% | 2.74% | 3.14% | 1.16% |